The biocompatibility of silver and hydroxyapatite coatings on titanium dental implants with human primary osteoblast cells

2021-09-17

Ranj Nadhim Salaie, Alexandros Besinis, Huirong Le, Christopher Tredwin, Richard D. Handy*. Materials Science and Engineering: C-Materials for Biological Applications 107 (2020), paper no. 110210.

Ranj Nadhim Salaie, Alexandros Besinis, Huirong Le, Christopher Tredwin, Richard D. Handy*. The biocompatibility of silver and hydroxyapatite coatings on titanium dental implants with human primary osteoblast cells.  Materials Science and Engineering: C-Materials for Biological Applications 107 (2020), paper no. 110210.


Abstract

Silver nanoparticles (Ag NPs) are antimicrobial, with potential uses in medical implants, but Ag NPs alone can also be toxic to mammalian cells. This study aimed to enhance the biocompatibility of Ag NP-coated titanium dental implants with hydroxyapatite (HA) applied to the surface. Ti6Al4V discs were coated with Ag NPs, Ag NPs plus HA nanoparticles (Ag + nHA), or Ag NPs plus HA microparticles (Ag + mHA). The stability of coatings was explored and the biocompatibility with primary human osteoblasts over 7 days. Results showed that Ti6Al4V discs were successfully coated with silver and HA. The primary particle size of nHA and mHA were 23.90 ± 1.49 nm and 4.72 ± 0.38 μm respectively. Metal analysis showed that underlying silver coatings remain stable in DMEM culture media, but the presence of FBS in the media caused some initial (clinically beneficial) release of dissolved silver. With additions of HA, osteoblasts were adherent, had normal morphology, negligible lactate dehydrogenase (LDH) leak, and showed alkaline phosphatase (ALP) activity. Cell viability was around 70% throughout the Ag + nHA treatment. Overall, the implants coated with Ag + nHA maintained a higher degree of biocompatibility compared to those coated with Ag + mHA, or Ag NPs alone, suggesting the former has a benefit for clinical use.